Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders
- Author(s)
- Dobson, H; Al Maawali, S; Malpas, C; Santillo, AF; Kang, M; Todaro, M; Watson, R; Yassi, N; Blennow, K; Zetterberg, H; Foster, E; Neal, A; Velakoulis, D; O'Brien, TJ; Eratne, D; Kwan, P;
- Journal Title
- Epilepsia
- Publication Type
- Jul 20 epub ahead of print
- Abstract
- OBJECTIVE: Research suggests that recurrent seizures may lead to neuronal injury. Neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAP) levels increase in cerebrospinal fluid and blood in response to neuroaxonal damage, and they have been hypothesized as potential biomarkers for epilepsy. We examined plasma NfL and GFAP levels and their diagnostic utility in differentiating patients with epilepsy from those with psychogenic nonepileptic seizures (PNES) and other nonepileptic disorders. METHODS: We recruited consecutive adults admitted for video-electroencephalographic monitoring and formal neuropsychiatric assessment. NfL and GFAP levels were quantified and compared between different patient groups and an age-matched reference cohort (n = 1926) and correlated with clinical variables in patients with epilepsy. RESULTS: A total of 138 patients were included, of whom 104 were diagnosed with epilepsy, 22 with PNES, and 12 with other conditions. Plasma NfL and GFAP levels were elevated in patients with epilepsy compared to PNES, adjusted for age and sex (NfL p = .04, GFAP p = .04). A high proportion of patients with epilepsy (20%) had NfL levels above the 95th age-matched percentile compared to the reference cohort (5%). NfL levels above the 95th percentile of the reference cohort had a 95% positive predictive value for epilepsy. Patients with epilepsy who had NfL levels above the 95th percentile were younger than those with lower levels (37.5 vs. 43.8 years, p = .03). SIGNIFICANCE: An elevated NfL or GFAP level in an individual patient may support an underlying epilepsy diagnosis, particularly in younger adults, and cautions against a diagnosis of PNES alone. Further examination of the association between NfL and GFAP levels and specific epilepsy subtypes or seizure characteristics may provide valuable insights into disease heterogeneity and contribute to the refinement of diagnosis, understanding pathophysiological mechanisms, and formulating treatment approaches.
- Publisher
- Wiley
- Research Division(s)
- Population Health And Immunity
- PubMed ID
- 39032019
- Publisher's Version
- https://doi.org/10.1111/epi.18065
- Open Access at Publisher's Site
https://doi.org/10.1111/epi.18065- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-31 03:30:19
Last Modified: 2024-07-31 03:38:25